AbbVie

Publisher IV

Posted on: 15 Jan 2021

Chicago, IL

Job Description

About AbbVie
AbbVies mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on peoples lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, womens health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

The Publisher IV works with RA Area & Affiliate colleagues, and cross-functional submission teams to publish and quality check low to high impact (with respect to internal visibility, risk, complexity, and criticality) submissions Coordinates submission publishing with offsite publishers. Creates cover letters and forms for Investigational New Drug (IND), New Drug Application (NDA), Drug Master File (DMF) and Biologic License Application (BLA) submissions. Manages IND safety report, NDA/BLA/DMF annual reports, and 30-day investigator submissions independently. Drafts summary documents for annual reports. Manages departmental routine submission schedules. Works with minimal supervision. Suggests and may assist in the implementation of process improvements.

* Publishes low - high impact (with respect to internal visibility, risk, complexity and criticality) submissions, creating compliant submissions to be used in global regulatory submissions. Submissions are intricately linked into a cohesive product that can be easily reviewed by a regulatory agency.
* Performs detailed quality reviews of published output to ensure compliance with Regulatory Standards and Health Authority guidances. Includes verification of bookmarks, hypertext links and tables of content in global submissions. Prepares, QCs, ships and archives AdPromo submissions. Coordinates submissions with offsite publishers.
* Transmits submission to FDA, archives submission and sends submission notifications.
* Creates cover letters and forms for Investigational New Drug (IND), New Drug Application (NDA), Biologic License Application (BLA), Drug Master File (DMF) submissions and independently manages IND 30-day investigator update, safety report and NDA, BLA and DMF annual reports. Drafts summary documents NDA, BLA, DMF annual reports.
* Lead submission publishing for large new NDA/BLA submission, assign tasks to other publishers and coordinate multitude of activities. Expedites, manages and coordinates a multitude of concurrent interrelated activities for teams and/or multiple products in the development of published Global submissions within the required timelines.
* Represents Publishing on submission teams as necessary, elevates timeline issues.
* Creates and finalizes internal process and standards documents relating to publishing and publishing deliverables. Assists in the implementation, testing, validation of software updates or enhancements. Tracks departmental metrics and metrics associated with submission publishing and rework.
* Trains, mentors and may supervise the work of less experienced staff.
* Publishes core package and country specific formatted submissions for Latin American countries. Acts as publishing representative on cross-functional teams such as process improvement teams.
* May also be assigned to work on Advertising and Promotion submissions for FDA OPDP.

Qualifications
* Required Education: High School diploma or equivalent
* Preferred Education: Bachelors Degree
* Required Experience: Five years pharmaceutical or industry related experience
* Experience with publishing related software tools e.g. Documentum, eCTDXPress/ISIPublisher/DocuBridge/Insight platform, ISI Toolbox, Adobe Acrobat
* Experience in a complex and matrix environment. Strong communication skills both oral and written
* Preferred Experience: Five years creating reports and/or regulatory submissions, working with customers in planning and compilation of reports or submissions
* Experience with technical capabilities in the areas of scanning and bookmarking
* NOTE: Higher education may compensate for years of experience. Years of experience may also compensate for lower education.
* Good organizational and time management skills.

Significant Work Activities
Continuous sitting for prolonged periods (more than 2 consecutive hours in an 8 hour day)
Keyboard use (greater or equal to 50% of the workday)
Travel
Yes, 5 % of the Time
Job Type
Experienced
Schedule
Full-time
Job Level Code
IC
Equal Employment Opportunity
At AbbVie, we value bringing together individuals from diverse backgrounds to develop new and innovative solutions for patients. As an equal opportunity employer we do not discriminate on the basis of race, color, religion, national origin, age, sex (including pregnancy), physical or mental disability, medical condition, genetic information gender identity or expression, sexual orientation, marital status, protected veteran status, or any other legally protected characteristic.

AbbVie

Chicago, IL

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products in the United States, Japan, Germany, Canada, Italy, Spain, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenström’s macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection.

It also provides KALETRA, an anti-human immunodeficiency virus (HIV)-1 medicine used with other anti-HIV-1 medications to maintain viral suppression in HIV-1 patients; NORVIR, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and SYNAGIS to prevent respiratory syncytial virus infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron to treat prostate cancer, endometriosis, and central precocious puberty, as well as anemia.

Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product; and ORILISSA, a non-peptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain. It has collaborations with Alector, Inc.; Janssen Biotech, Inc.; Galapagos; Bristol-Myers Squibb Company; and Calico Life Sciences LLC. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.